A detailed history of Aquatic Capital Management LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Aquatic Capital Management LLC holds 35,200 shares of IOVA stock, worth $269,280. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,200
Holding current value
$269,280
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.28 - $11.9 $256,256 - $418,880
35,200 New
35,200 $330,000
Q1 2024

May 15, 2024

BUY
$7.59 - $17.47 $166,221 - $382,593
21,900 New
21,900 $324,000
Q1 2023

May 15, 2023

BUY
$5.53 - $8.22 $58,065 - $86,310
10,500 New
10,500 $64,000
Q3 2022

Nov 14, 2022

BUY
$9.53 - $13.11 $548,928 - $755,136
57,600 Added 553.85%
68,000 $651,000
Q2 2022

Aug 15, 2022

BUY
$6.38 - $18.33 $63,162 - $181,466
9,900 Added 1980.0%
10,400 $115,000
Q1 2022

May 16, 2022

BUY
$12.38 - $19.1 $6,190 - $9,550
500 New
500 $8,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.21B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.